Oct 21, 2024 Posted on 21 October 20246 November 2024 Sanofi in ‘exclusive negotiations’ to sell 50% stake in €16B consumer health unit Opella
Oct 17, 2024 Posted on 17 October 202417 October 2024 Bayer applies for EU approval of menopause drug elinzanetant
Oct 07, 2024 Posted on 7 October 20247 October 2024 Oncolytics targets accelerated approval for oncolytic virus therapy
Oct 04, 2024 Posted on 4 October 20244 October 2024 US’ top IV fluid maker Baxter voices uncertainty about recovery timeline at North Carolina facility hit by Helene
Oct 01, 2024 Posted on 1 October 20244 October 2024 Recordati to acquire worldwide rights to Sanofi’s antibody Enjaymo
